Filtered By:
Specialty: Neurology
Countries: USA Health

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 260 results found since Jan 2013.

Significance of concurrent ipsilateral intracranial carotid artery stenosis in carotid revascularization
A 71-year-old male presenting with a transient ischemic attack was found to have an ipsilateral severe proximal right internal carotid artery (ICA) stenosis as graded per the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. He was subsequently treated with right internal carotid endarterectomy (CEA). The surgery was complicated by a right sided watershed infarction determined by magnetic resonance imaging (MRI) of the head. His post-surgery National Institutes of Health Stroke Scale score was 6 and the 90  days modified Rankin Scale score was 3.
Source: Journal of the Neurological Sciences - February 19, 2021 Category: Neurology Authors: Riwaj Bhagat, Allison Muha Tags: Letter to the Editor Source Type: research

Corrigendum to ‘Health Behaviors among Stroke Survivors in the United States: A Propensity Score-Matched Study’ Journal of Stroke & Cerebrovascular Diseases, Vol. 27, No. 8 (August), 2018: pp 2124 –2133
The authors regret to inform the readers that there was an unnoticed mistake in the paper. An affiliation of Dr. Wali was not listed at the time of publication due to an oversight from the author. The aforementioned missing affiliation is the following: Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
Source: Journal of Stroke and Cerebrovascular Diseases - February 9, 2021 Category: Neurology Authors: Haytham Wali, Sawsan Kurdi, Jawad Bilal, Irbaz Bin Riaz, Sandipan Bhattacharjee Tags: Corrigendum Source Type: research

Trends in ischemic stroke outcomes in a rural population in the United States
The stroke mortality rate has gradually declined due to improved interventions and controlled risk factors. We investigated the trends in stroke recurrence and all-cause mortality in stroke patients from a rural population in the United States between 2004 and 2018.
Source: Journal of the Neurological Sciences - February 8, 2021 Category: Neurology Authors: Durgesh Chaudhary, Ayesha Khan, Shima Shahjouei, Mudit Gupta, Clare Lambert, Venkatesh Avula, Clemens M. Schirmer, Neil Holland, Christoph J. Griessenauer, M. Reza Azarpazhooh, Jiang Li, Vida Abedi, Ramin Zand Source Type: research

Mobile Stroke Units: Current and Future Impact on Stroke Care
Semin Neurol DOI: 10.1055/s-0040-1722724Ischemic stroke is a leading cause of death and major disability that impacts societies across the world. Earlier thrombolysis of blocked arteries with intravenous tissue plasminogen activator (tPA) and/or endovascular clot extraction is associated with better clinical outcomes. Mobile stroke units (MSU) can deliver faster tPA treatment and rapidly transport stroke patients to centers with endovascular capabilities. Initial MSU trials in Germany indicated more rapid tPA treatment times using MSUs compared with standard emergency room treatment, a higher proportion of patients treated...
Source: Seminars in Neurology - January 28, 2021 Category: Neurology Authors: Bowry, Ritvij Grotta, James C. Tags: Review Article Source Type: research

Impact of the COVID-19 pandemic on stroke epidemiology and clinical stroke practice in the US
: To examine the impact of the COVID-19 pandemic on stroke, the number of stroke patients, time since last known well (LKW), morbidity, and mortality of stroke patients in Southwest Healthcare System (SHS), California (CA) and the United States (US) were analyzed during 2019 and compared to 2020. Our hypothesis is that there are regional differences in stroke outcome depending on location during the COVID-19 study period which influences stroke epidemiology and clinical stroke practice.
Source: Journal of Stroke and Cerebrovascular Diseases - January 26, 2021 Category: Neurology Authors: Daniel Friedlich, Tali Newman, Stephanie Bricker Source Type: research

Tenecteplase for Acute Ischemic Stroke Treatment
Semin Neurol DOI: 10.1055/s-0040-1722722The introduction of thrombolytic therapy in the 1990s has transformed acute ischemic stroke treatment. Thus far, intravenous recombinant tissue plasminogen activator (rt-PA) also known as alteplase is the only thrombolytic proven to be efficacious and approved by the United States Food and Drug Administration. But the thrombolytic agent tenecteplase (TNK) is emerging as a potential replacement for rt-PA. TNK has greater fibrin specificity, slower clearance, and higher resistance to plasminogen activator inhibitor-1 than rt-PA. Hence, TNK has the potential to provide superior lysis wi...
Source: Seminars in Neurology - January 20, 2021 Category: Neurology Authors: Baird, Alison E. Jackson, Richard Jin, Weijun Tags: Review Article Source Type: research

The Joint Association of Septicemia and Cerebrovascular Diseases with In-Hospital MortalityAmong Patients with Left Ventricular Assist Device in the United States
Currently, about 6.2 million adults in the US are reported to have heart failure, and this prevalence is expected to increase by 46% by 2030.1 The prognosis of advanced heart failure especially, advanced systolic heart failure, has improved tremendously with the advent of implantable mechanical circulatory support devices such as left ventricular assist device (LVAD) which is often used as a bridge to heart transplantation or as a destination therapy.2,3 Indeed, LVAD has improved the 1-year survival of patients with advanced heart disease from 52% to about 85%.
Source: Journal of Stroke and Cerebrovascular Diseases - January 19, 2021 Category: Neurology Authors: Jessica Lovelace, Obadeh Shabaneh, Noah De La Cruz, Damilola R. Owoade, Chike C. Nwabuo, Nandini Nair, Duke Appiah Source Type: research

Patient Characteristics and Outcomes Associated with Decline in Stroke Volumes during the Early COVID-19 Pandemic
Recent studies have documented a decrease in evaluations of stroke patients during the early weeks of the coronavirus disease 2019 (COVID-19) outbreak in the United States (US).1 –4 This phenomenon raises concern that delays in emergent treatment and implementation of secondary stroke prevention measures may contribute to the morbidity and mortality of the pandemic. As a second wave of COVID-19 sweeps through the country, there is an urgent need for public health communica tion that targets populations most likely to delay evaluation for stroke-like symptoms.
Source: Journal of Stroke and Cerebrovascular Diseases - December 25, 2020 Category: Neurology Authors: Adam N. Wallace, Kaiz S. Asif, Daniel H. Sahlein, Steven J. Warach, Timothy Malisch, E. Francis LaFranchise, Scott Geraghty, K. Derek Kreitel, Marian P. Lamonte, Jefferson T. Miley, Daniel P. Gibson, Krishna Amuluru Source Type: research

Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States
Studies have shown worse outcomes in patients with comorbid ischemic stroke (IS) and coronavirus disease 2019 (COVID-19), but have had small sample sizes.
Source: Journal of Stroke and Cerebrovascular Diseases - December 9, 2020 Category: Neurology Authors: Adam de Havenon, John P. Ney, Brian Callaghan, Alen Delic, Samuel Hohmann, Ernie Shippey, Gregory J. Esper, Eric Stulberg, David Tirschwell, Jennifer Frontera, Shadi Yaghi, Mohammad Anadani, Jennifer J. Majersik Source Type: research

Endovascular Treatment Decision Making in Patients with Low Baseline ASPECTS: Insights from UNMASK EVT, an International Multidisciplinary Study
Endovascular therapy is a highly effective treatment for acute ischemic stroke (AIS) due to large vessel occlusion (LVO)1 and now considered standard of care.2 In most randomized EVT trials, patients with low Alberta Stroke Program Early CT Score (ASPECTS) scores were either excluded or underrepresented. Hence, current European and North American guidelines for the early management of patients with acute ischemic stroke restrict level 1A recommendations for endovascular therapy (EVT) to patients with baseline ASPECTS score>5.
Source: Journal of Stroke and Cerebrovascular Diseases - October 29, 2020 Category: Neurology Authors: Johanna Maria Ospel, Ravinder Singh, Nima Kashani, Mohammed Almekhlafi, Alexis Wilson, Urs Fischer, Bruce Campbell, Shinichi Yoshimura, Francis Turjman, Pillai Sylaja, Ji-Hoe Heo, Michael D. Hill, Gustavo Saposnik, Mayank Goyal, Bijoy Menon Source Type: research

Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study
We examined outcomes and Medicare payments following any severity IS or TIA as well as the subgroup with minor IS or high-risk TIA.
Source: Journal of Stroke and Cerebrovascular Diseases - October 23, 2020 Category: Neurology Authors: Brystana G. Kaufman, Shreyansh Shah, Anne S. Hellkamp, Barbara L. Lytle, Gregg C. Fonarow, Lee H. Schwamm, Eva Les én, Jonatan Hedberg, Amarjeet Tank, Edmond Fita, Narinder Bhalla, Nipun Atreja, Janet Prvu Bettger Source Type: research

Cryptogenic stroke: Contemporary trends, treatments, and outcomes in the United States
Conclusions In a large contemporary nationwide registry, CS accounted for 20% of ISs among patients with a documented stroke etiology. Patients with CS had a distinct profile of treatments and outcomes relative to other subtypes. Improved subtype documentation and further research into CS are warranted to improve care and outcomes for patients with stroke.
Source: Neurology Clinical Practice - October 12, 2020 Category: Neurology Authors: Prabhakaran, S., Messe, S. R., Kleindorfer, D., Smith, E. E., Fonarow, G. C., Xu, H., Zhao, X., Lytle, B., Cigarroa, J., Schwamm, L. H. Tags: All Cerebrovascular disease/Stroke Research Source Type: research

Timing of Recognition for Perioperative Strokes Following Cardiac Surgery
Cerebrovascular disease represents one of the largest burdens to mortality, morbidity, and healthcare associated costs both in the United States and globally.1 –3 While prevention should be the primary strategy especially in patients with stroke risk factors, early recognition of strokes provides opportunity for revascularization that limits morbidity and mortality.4 Paradoxically, strokes that occur during hospitalizations have been shown to result in l ower rates of early detection, increased wait times to intervention, and poorer overall outcomes.
Source: Journal of Stroke and Cerebrovascular Diseases - September 29, 2020 Category: Neurology Authors: Beret Amundson, Joseph Hormes, Anna Katema, Priyadharshi Rathakrishnan, J. Kirk Edwards, Gregory Esper, Jose Binongo, Yi Lasanajak, Brent Keeling, Michael Halkos, Fadi Nahab Source Type: research

YouTube as a Source of Information for Transcranial Magnetic Stimulation in Stroke: A Quality, Reliability and Accuracy Analysis
Stroke is one of the major causes of death and disability among adults and affects more than 795000 people each year in the United States.1,2 Globally, 6.5 million stroke deaths occurred in 2013 and stroke was the 2nd most common cause of mortality worldwide.2,3 Usually, after a stroke, the damaged brain region and surrounding healthy cells try to repair the disrupted neural networks and to regulate the disrupted functions by creating new networks. However, the complete recovery of motor functions takes place in only 20% of patients, depending on the location of the damaged area, its size, and the general health of the patient.
Source: Journal of Stroke and Cerebrovascular Diseases - September 21, 2020 Category: Neurology Authors: Ayhan Askin, lker Sengul, Aliye Tosun Source Type: research

Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey
We sought to understand practice patterns in management of patients who have ischemic stroke while adherent to oral anticoagulation for non-valvular atrial fibrillation (NVAF) in the United States (US).
Source: Journal of Stroke and Cerebrovascular Diseases - September 11, 2020 Category: Neurology Authors: Setareh Salehi Omran, Neal S. Parikh, Maria Zambrano Espinoza, Mackenzie P. Lerario, Steven R. Levine, Hooman Kamel, Randolph Marshall, Joshua Willey Source Type: research